Legend Biotech Corporation Announces Pricing of Public Offering
Legend Biotech priced an underwritten public offering of 7.7 million American Depositary Shares at $29.35 per ADS, targeting gross proceeds of approximately $226 million. Underwriters have a 30-day option to purchase an additional 1.155 million ADSs, representing potential additional dilution.
Key figures
- Deal Value Usd
- 226000000
- Offering Price
- 29.35
- Shares Offered
- 7700000
- Greenshoe shares
- 1155000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.